000 03177nam a22004695i 4500
001 978-3-642-28702-2
003 DE-He213
005 20140220083313.0
007 cr nn 008mamaa
008 121204s2012 gw | s |||| 0|eng d
020 _a9783642287022
_9978-3-642-28702-2
024 7 _a10.1007/978-3-642-28702-2
_2doi
050 4 _aRC254-282
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
100 1 _aGu, Jianren.
_eauthor.
245 1 0 _aPrimary Liver Cancer
_h[electronic resource] :
_bChallenges and Perspectives /
_cby Jianren Gu.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2012.
300 _aXXIV, 462 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aIntroduction: Concept, Challenges and Perspectives -- Systems Biological Survey for Cancer Research -- Systemic Regulation in the Development of Hepatocellular Carcinoma -- Genomics, Epigenomics of Hepatocellular Carcinoma -- Biomarkers of Hepatocellular Carcinoma -- Metabonomics of Hepatocellular Carcinoma -- Signal Transduction in Hepatic Cancer -- Cancer Stem Cells of Hepatocellular Carcinoma -- Immunology of Liver -- Immunology and Hepatic Cancer -- Immune Therapy of Hepatic Cancer -- Epidermiology of Primary Liver Cancer -- Molecular Carcinogenesis of Hepatic Cancer -- Chemo-intervention of the Development of Hepatic Cancer -- HBV and Hepatocellular Carcinoma -- Metastasis of Hepatic Cancer -- Integrated Treatment of Hepatic Cancer -- Liver Transplantation for Treatment of Hepatic Cancer.
520 _a"Primary Liver Cancer: Challenges and Perspectives" presents the recent progress in basic and clinical research in Primary Liver Cancer (PLC) in China and around the world. PLC patients in China make up more than 50% of the total patients worldwide. By contributing to the book, the leading experts in the field of liver cancer in China as well as in the US share with readers their new concepts, practices, and experiences from bench to bed, from population study to individual survey, from molecular search to clinical practice, and from early diagnosis to treatment. The book is intended for researchers in the fields of epidemiology, molecular genetics, cell biology, immunology of HCC and other cancers, and clinical oncology in primary liver cancer. Jianren Gu is a Professor of molecular oncology at the Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine and Academician of Chinese Academy of Engineering.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aImmunology.
650 0 _aEpidemiology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aOncology.
650 2 4 _aEpidemiology.
650 2 4 _aImmunology.
650 2 4 _aCancer Research.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642287015
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-28702-2
912 _aZDB-2-SME
999 _c102868
_d102868